Symbol="KZIA"
AssetType="Common Stock"
Name="Kazia Therapeutics Ltd ADR"
Description="Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia."
CIK="1075880"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, AUSTRALIA"
FiscalYearEnd="June"
LatestQuarter="2022-09-30"
MarketCapitalization="22277100"
EBITDA="-23103516"
PERatio="None"
PEGRatio="None"
BookValue="0.71"
DividendPerShare="0"
DividendYield="0"
EPS="-1.21"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.432"
ReturnOnEquityTTM="-1.35"
RevenueTTM="0"
GrossProfitTTM="10000"
DilutedEPSTTM="-1.21"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.997"
AnalystTargetPrice="1.99"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="897.79"
PriceToBookRatio="0.688"
EVToRevenue="0.943"
EVToEBITDA="-0.179"
Beta="2.104"
num_52WeekHigh="1.87"
num_52WeekLow="0.5"
num_50DayMovingAverage="1.071"
num_200DayMovingAverage="0.983"
SharesOutstanding="23633400"
DividendDate="2017-07-14"
ExDividendDate="None"
symbol="KZIA"
open="0.96"
high="0.97"
low="0.88"
price="0.93"
volume="9048.00"
latest_trading_day="2023-08-16"
previous_close="0.90"
change="0.02"
change_percent="2.6383%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="30"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="136214"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_30"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="146"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0030.jpeg"
image_negative_thumbnail_id_2="142"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="1014"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0176.jpeg"
image_positive_thumbnail_id_2="949"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
